Table 2.
Disease remission vs. recurrence in all patients.
| Total: 116 patients | Remission | Recurrence | p-value |
|---|---|---|---|
| Patients | 58 | 58 | |
| Age | 49.7 | 48.0 | p = 0.490 |
| Male | 27 (46.6%) | 30 (51.7%) | p = 0.577 |
| Female | 31 (53.4%) | 28 (48.3%) | |
| Asthma | 33 (56.9%) | 42 (72.4%) | p = 0.080 |
| Previous ESS | 32 (55.2%) | 48 (82.8%) | p = 0.001 |
| Smoking | |||
| Never | 24 (41.4%) | 28 (48.3%) | p = 0.591 |
| Active | 11 (19.0%) | 8 (13.8%) | |
| Former | 23 (39.6%) | 22 (37.9%) | |
| Polyposis | 57 (98.3%) | 51 (87.9%) | p = 0.061 |
| Race | |||
| Caucasian | 52 (89.7%) | 52 (89.7%) | p = 1.000 |
| Hispanic | 3 (5.2%) | 3 (5.2%) | |
| Asian | 1 (1.7%) | 1 (1.7%) | |
| Arabic | 2 (3.4%) | 2 (3.4%) | |
| Allergies (all types) | 48 (82.8%) | 42 (72.4%) | p = 0.182 |
| Seasonal | 27 (46.6%) | 17 (29.3%) | p = 0.056 |
| NSAID | 7 (12.1%) | 16 (27.6%) | p = 0.036 |
| S. aureus (pre-ESS) | 4 (7.3%) | 14 (24%) | p = 0.020 |
| S. aureus (post-ESS) | 7 (13.0%) | 24 (47.1%) | p < 0.001 |
| P. aeruginosa (pre-ESS) | 1 (1.8%) | 5 (8.6%) | p = 0.207 |
| P. aeruginosa (post-ESS) | 1 (1.9%) | 6 (11.8%) | p = 0.056 |
| Gram negative (pre-ESS) | 13 (23.6%) | 12 (20.7%) | p = 0.706 |
| Gram negative (post-ESS) | 6 (11.1%) | 13 (25.5%) | p = 0.056 |
| SNSS (post-ESS) | 4.4 | 5.2 | p = 0.306 |
| SNOT22 (post-ESS) | 25.5 | 32.6 | p = 0.098 |
| Lund-Kennedy (post-ESS) | 0.98 | 6.3 | p < 0.001 |